Lv6
2580 积分 2023-11-18 加入
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
1个月前
已完结
Twice-Yearly Depemokimab Demonstrates an Acceptable Safety Profile in a 12-Month Interim Analysis of the AGILE Phase III Open-Label Extension Study
1个月前
已完结
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
1个月前
已完结
经皮冠状动脉介入治疗指南（2025）
2个月前
已完结
《冠心病合并抑郁焦虑的认知临床诊疗指南》的团体标准
2个月前
已完结
急性胸痛急诊诊疗专家共识
3个月前
已完结
[Expert consensus on exercise rehabilitation in outpatient of cardiovascular disease]
4个月前
已完结
Traditional medicine Kuanxiong Aerosol alleviates atherosclerotic plaque inflammation by mitigating CX3CR1+ macrophage apoptosis via the cGAS–STING pathway
6个月前
已完结
皖公网安备34019202002308
